LogoFDA 510(k) Search
Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K990139
    Device Name
    KENSTONE
    Manufacturer
    KENDA USA
    Date Cleared
    1999-04-29

    (100 days)

    Product Code
    IOR
    Regulation Number
    890.3850
    Type
    Traditional
    Panel
    Physical Medicine
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    THIS DEVICE IS A CHAIR WITH LARGE WHEELS WHICH ARE USED TO MOVE AND TURN THE CHAIR BY THE USER. IT CAN BE USED ON A FLAT SURFACE IN A ROOM, A YARD, OR PAVED SURFACE. IT IS ESPECIALLY USEFUL TO THOSE WHO ARE UNABLE TO WALK OR LACK USE OF THEIR LEGS, ALLOWING THE USER A DEGREE OF MOBILITY. THIS CHAIR DOES NOT HAVE A RECLINING FEATURE.

    Device Description

    Mechanical (manual) wheelchair #KE-1M

    AI/ML Overview

    The provided text describes a Premarket Notification 510(k) Summary for a "Mechanical (manual) wheelchair #KE-1M" by KENSTONE METAL CO., LTD. This document focuses on establishing substantial equivalence to a predicate device rather than presenting a study with specific acceptance criteria and performance data for a complex medical device with an AI component. Therefore, I cannot extract the requested information about acceptance criteria, study details, sample sizes, expert qualifications, adjudication methods, MRMC studies, standalone performance, or ground truth for training/test sets.

    The document primarily provides administrative and regulatory details:

    • Applicant: KENSTONE METAL CO., LTD.
    • Device Name: Mechanical (manual) wheelchair #KE-1M
    • Trade Name: Kenstone
    • Classification: Class 1
    • Equivalent Device: Graham Field Vista Model 31-52005510
    • Intended Use: To aid mobility of persons having difficulty walking
    • Technological characteristics: Function and design is same as equivalent device
    • K Number: K990139
    • FDA Decision Date: April 29, 1999

    The FDA's letter states that the device is "substantially equivalent" to legally marketed devices, allowing it to proceed to market under general controls. This type of 510(k) submission generally relies on demonstrating that the new device has the same intended use, technological characteristics, and safety/effectiveness profile as a predicate device, often without requiring extensive clinical trials with pre-defined acceptance criteria and statistical performance measures as would be expected for novel or high-risk devices, especially those incorporating AI.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1